Home / Clinical trials / GHK-Cu
Are there clinical trials for GHK-Cu?
GHK-Cu has 4 registered clinical trials reaching Phase 4, with 3 currently active, but 1 completed interventional studies so far.
Trial breakdown
By phase
| Phase 4 | 1 |
| Phase 2 | 1 |
| Not applicable | 1 |
| Early Phase 1 | 1 |
By status
| Completed | 1 |
| Recruiting | 1 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
Active trials
- Two-Part Study of the Effects of the X39 Patch on Circulating GHK and GHK-Cu Levels in Healthy AdultsNot applicable · Not yet recruiting · 100 participants · LifeWave, Inc. · started 2027-01NCT07706361
- Systemic and Topical Geroprotective Rejuvenation Assessed by START/REST Aging ClocksEarly Phase 1 · Enrolling by invitation · 48 participants · Frontiers in Bioscience Research Institute and Aging · started 2026-10-21NCT07888595
- Topical GHK-Cu Gel for Acute Skin Wound HealingPhase 2 · Recruiting · 60 participants · Hudson Biotech · started 2026-02-02NCT07437586
Most recent registered trials
- Two-Part Study of the Effects of the X39 Patch on Circulating GHK and GHK-Cu Levels in Healthy AdultsNot applicable · Not yet recruiting · 100 participants · LifeWave, Inc. · started 2027-01NCT07706361
- Systemic and Topical Geroprotective Rejuvenation Assessed by START/REST Aging ClocksEarly Phase 1 · Enrolling by invitation · 48 participants · Frontiers in Bioscience Research Institute and Aging · started 2026-10-21NCT07888595
- Topical GHK-Cu Gel for Acute Skin Wound HealingPhase 2 · Recruiting · 60 participants · Hudson Biotech · started 2026-02-02NCT07437586
- Trial Assessing the Impact on Facial Skin Quality, Hydration, and Skin Barrier of Three (3) Hydrafacial Treatments in Adults of All Skin Types.Phase 4 · Completed · 27 participants · Austin Institute for Clinical Research · started 2023-11-20NCT05932732
What GHK-Cu is being studied for
Most studied conditions
Who is running the studies
Counted from ClinicalTrials.gov registrations, checked 2026-11-09.
Peptides with a similar weight of evidence
Ordered by how far the registered research has progressed.
- MOTS-c5 registered studies
- BPC-1574 registered studies
- Ipamorelin3 registered studies
- Selank2 registered studies
- CJC-12951 registered study
Frequently asked questions
Are there clinical trials for GHK-Cu?
GHK-Cu has 4 registered clinical trials reaching Phase 4, with 3 currently active, but 1 completed interventional studies so far.
Does a registered trial mean the peptide works?
No. Registration means a study was formally listed before or during the research. It says nothing about the result. A completed trial can find no benefit, and many registered studies are never published.
What is the difference between a registered trial and published evidence?
Registration records that a study exists. Publication reports what it found. This page counts registrations, which is the more complete picture of research activity, but it is not a measure of proven effectiveness.
Why do phases matter?
Phase 1 tests safety in a small group. Phase 2 looks for early signs of effect. Phase 3 tests effectiveness against a comparator in a large group, and is what regulators normally require. Phase 4 studies happen after approval. A compound with only Phase 1 trials has not been shown to work.
Source: ClinicalTrials.gov API v2, U.S. National Library of Medicine. Studies where GHK-Cu is registered as an intervention. Last updated 2026-11-09.
Related data
- Which peptides are FDA-approved →Approval status for every peptide, from Drugs@FDA
- Which peptides have clinical evidence →Registered clinical trial counts from ClinicalTrials.gov
- Peptide legality by US state →A sourced verdict for all 50 states
